Is the use of low molecular weight heparin a rational choice during pregnancy in patients with a mechanical heart valve: A report of three cases
Turk Kardiyoloji Dernegi Arsivi, cilt.47, sa.1, ss.63-68, 2019 (Scopus, TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 47 Sayı: 1
- Basım Tarihi: 2019
- Doi Numarası: 10.5543/tkda.2018.83364
- Dergi Adı: Turk Kardiyoloji Dernegi Arsivi
- Derginin Tarandığı İndeksler: Scopus, TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.63-68
- Anahtar Kelimeler: Low molecular weight heparin, mechanical heart valve, prosthetic valve thrombosis
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Pregnancy is associated with an increased risk of valve thrombosis in patients with a mechanical prosthetic heart valve. The administration of low molecular weight heparin (LMWH) with regular anti-factor Xa assessment is a recommended treatment modality for these patients. Presently described are 3 cases of therapy with LMWH during pregnancy. Despite frequent anti-factor Xa monitoring, not surprisingly, all of them developed prosthetic valve thrombosis.